Uday Baldota

Rediff.com » News » Uday Baldota

News for Uday Baldota

Business

Sun Pharma open to large acquisitions post Ranbaxy

India's largest drugmaker Sun Pharmaceutical Industries Ltd will look at making more large acquisitions even as it winds up a $3.2 billion deal to buy smaller rival Ranbaxy Laboratories Ltd. The......

Sun-Ranbaxy merger clears last hurdle

The merger gets Punjab & Haryana High Court go-ahead; deal to close after brand dilutions The $4-billion merger between Sun Pharmaceutical Industries and Ranbaxy Laboratories has crossed the final......

Post takeover, Sun Pharma to rebrand Ranbaxy drugs in the US

India's Sun Pharmaceutical Industries Ltd plans to begin phasing out sales of generic drugs branded as Ranbaxy Laboratories Ltd products in the United States after completing a $3.2 billion......

Stronger rupee a risk to future corporate earnings

Corporate India's earnings in the past two quarters were largely driven by the rupee's sharp fall versus the dollar in the second quarter of this financial year. But the recent surge in the......

Sun Pharma keen to enter Japan's generics market

Sun Pharmaceutical Industries Ltd, India's biggest drugmaker by market value, is looking for partnerships or acquisitions to enter Japan, an especially lucrative market for manufacturers of......

Rediff News

Uday Baldota

News for Uday Baldota

Sun Pharma open to large acquisitions post Ranbaxy

Sun-Ranbaxy merger clears last hurdle

Post takeover, Sun Pharma to rebrand Ranbaxy drugs in the US

Stronger rupee a risk to future corporate earnings

Sun Pharma keen to enter Japan's generics market

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS